Penserra Capital Management LLC Purchases 15,711 Shares of Danaher Co. (DHR)

Share on StockTwits

Penserra Capital Management LLC increased its position in Danaher Co. (NYSE:DHR) by 355.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,135 shares of the conglomerate’s stock after purchasing an additional 15,711 shares during the period. Penserra Capital Management LLC’s holdings in Danaher were worth $2,187,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. IMS Capital Management purchased a new stake in Danaher in the 2nd quarter valued at $107,000. BerganKDV Wealth Management LLC purchased a new stake in Danaher in the 2nd quarter valued at $111,000. Fort L.P. purchased a new stake in Danaher in the 2nd quarter valued at $119,000. Braun Bostich & Associates Inc. raised its position in Danaher by 506.4% in the 2nd quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after buying an additional 1,023 shares during the last quarter. Finally, Reilly Financial Advisors LLC raised its position in Danaher by 62.6% in the 3rd quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after buying an additional 501 shares during the last quarter. Institutional investors own 76.80% of the company’s stock.

Shares of Danaher stock opened at $104.39 on Friday. Danaher Co. has a 1 year low of $91.65 and a 1 year high of $110.13. The firm has a market cap of $72.94 billion, a PE ratio of 25.90, a price-to-earnings-growth ratio of 2.00 and a beta of 1.04. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.38.

Danaher (NYSE:DHR) last announced its earnings results on Thursday, October 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. Danaher had a return on equity of 11.59% and a net margin of 14.07%. The firm had revenue of $4.85 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same period last year, the firm posted $1.00 EPS. The business’s revenue was up 7.2% compared to the same quarter last year. Equities analysts expect that Danaher Co. will post 4.51 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, October 26th. Stockholders of record on Friday, September 28th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. The ex-dividend date of this dividend was Thursday, September 27th. Danaher’s dividend payout ratio is presently 15.88%.

DHR has been the subject of a number of analyst reports. Morgan Stanley increased their price target on Danaher from $113.00 to $120.00 and gave the company an “overweight” rating in a research report on Friday, July 13th. Zacks Investment Research lowered Danaher from a “hold” rating to a “sell” rating in a research report on Monday, July 16th. Bank of America set a $113.00 price target on Danaher and gave the company a “buy” rating in a research report on Thursday, July 19th. Royal Bank of Canada raised their target price on Danaher to $107.00 and gave the company a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. Finally, Robert W. Baird decreased their target price on Danaher from $116.00 to $114.00 and set an “outperform” rating for the company in a research report on Friday, October 19th. One research analyst has rated the stock with a hold rating and fifteen have given a buy rating to the stock. Danaher currently has an average rating of “Buy” and a consensus price target of $112.14.

In other news, insider Thomas Patrick Joyce, Jr. sold 5,212 shares of the stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $103.89, for a total transaction of $541,474.68. Following the completion of the transaction, the insider now owns 151,829 shares in the company, valued at approximately $15,773,514.81. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Daniel L. Comas sold 36,000 shares of the stock in a transaction on Thursday, November 8th. The stock was sold at an average price of $103.88, for a total value of $3,739,680.00. Following the transaction, the chief financial officer now owns 124,218 shares of the company’s stock, valued at approximately $12,903,765.84. The disclosure for this sale can be found here. Insiders have sold a total of 150,007 shares of company stock valued at $15,202,163 in the last quarter. 11.90% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This story was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://weekherald.com/2018/11/10/penserra-capital-management-llc-purchases-15711-shares-of-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Story: Stop Order

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply